Quiescent B Cells Acquire Sensitivity to Cell Cycle Arresting Agents by B Cell Receptor Stimulation.

Hosokawa, Takanatsu; Tanaka, Shinya; Mori, Takeshi; Baba, Yoshihiro; Katayama, Yoshiki

Hosokawa, Takanatsu; Tanaka, Shinya; Mori, Takeshi; Baba, Yoshihiro; Katayama, Yoshiki.

Afiliación

Hosokawa T; Graduate School of Systems Life Sciences, Kyushu University.
Tanaka S; Division of Immunology and Genome Biology, Medical Institute of Bioregulation, Kyushu University.
Mori T; Graduate School of Systems Life Sciences, Kyushu University.
Baba Y; Department of Applied Chemistry, Faculty of Engineering, Kyushu University.
Katayama Y; Division of Immunology and Genome Biology, Medical Institute of Bioregulation, Kyushu University.

Biol Pharm Bull ; 45(7): 847-850, 2022.

Article en En | MEDLINE | ID: mdl-35786592

Asunto(s)

Antineoplásicos; Receptores de Antígenos de Linfocitos B; Antineoplásicos/farmacología; Ciclo Celular; Puntos de Control del Ciclo Celular; División Celular

Palabras clave

B cell; B cell receptor stimulation; anticancer drug; cell cycle; quiescent phase

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Receptores de Antígenos de Linfocitos B / Antineoplásicos Tipo de estudio: Diagnostic_studies Idioma: En Revista: Biol Pharm Bull Asunto de la revista: BIOQUIMICA / FARMACOLOGIA Año: 2022 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google